Topline Media Messages for World TB Day 2011

Everyone in the world who needs TB care should be able to get it. That is not happening now.

Proof points/secondary messages:

• A third of people with TB are not reached with accurate diagnosis and appropriate care--that's about three million people each year. Most of them are in vulnerable and marginalized groups such as prisoners, slum dwellers, migrant workers, and drug users, or are living in poverty pockets.

• Civil society, health workers and businesses need to team up to drive universal access to TB care.

• In the 21st century, no one should die from TB, a curable disease. But at least 8 million people will die unnecessarily between now and 2015 if we don't take action.

2. Investing in TB saves lives - and TB is a cost-effective investment.

Proof points/secondary messages:

• It costs as little as $100 to provide life-saving care for drugsensitive TB in many developing countries.

• In 2006 the Disease Control Priorities Project counted TB treatment among the ten "best buys" in public health (DCPP, Disease Control Priorities in Developing Countries. 2006, Oxford University Press: New York. p. 289-309.)

• In 2009 researchers reported that countries could earn up to 10 times what they invest in TB care. (Economic Benefit of Tuberculosis Control, Ramanan Laxminarayan, Eili Klein, Christopher Dye, Katherine Floyd, Sarah Darley, Olusoji Adey here)

• In 2008 the Copenhagen Consensus ranked TB case finding and treatment fourth most cost-effective among interventions to control disease (CCC. Copenhagen Consensus 2008. 2008 [cited 2010 April 15]; Available here).


3. New genetic tests for TB will soon make it possible to rapidly identify everyone who needs TB treatment.

Proof points/secondary messages:

• Progress on rapid TB tests offers lots of promise, but we must also ensure that all will have access to the new test and that those who are diagnosed have access to high-quality TB care

• For every 100 people living with HIV who have MDR-TB: traditional microscopy will detect zero. Xpert will detect 95.

• For every 100 people living with HIV who have active, drugsusceptible TB: traditional microscopy will detect 40. Xpert 70-80

• 1 Xpert machine (the 4-module model) can test 4,000 people per year. Total cost is $100,000

• Greater investment in research will take us to the next critical step: a cheap, simple rapid TB test that can be used in any basic health care setting and requires little technical knowledge.

• The current treatment for TB is very long - six months or more. A new four-month treatment is on the horizon, but will only come to market if there is sufficient investment.

• We will not eliminate TB without a vaccine that is safe and effective in preventing the disease in people of all ages.

4. No one living with HIV should die from TB.

Proof points/secondary messages:

• There has been a huge investment in life-saving antiretroviral treatment, but TB takes the lives of far too many people infected with HIV and is threatening progress.

• Two million people living with HIV will die of TB between now and 2015 if we don't intensify efforts.

• All TB patients should be tested for HIV and all people in HIV care should be screened for TB. In places where TB represents a risk all people living with HIV should be receiving preventive treatment or anti-TB drugs as appropriate.

• In June, global leaders will meet at the UN in New York to seek a way forward on ending deaths from TB among people with HIV.

Share this